Mass General Brigham for the Brigham and Women’s Hospital
Date of Award
Crohn's Disease, Prevention
Term of Grant
Investigation of anti-GM-CSF autoantibodies as a disease determinant in Crohn’s disease
There is a need for the identification of accurate, non-invasive, and reliable biomarkers to accurately predict the onset and prognosis of Crohn’s disease. This project will help develop a non-invasive predictor that can detect CD at early stages, prior to disease onset and will allow for earlier interventions that could better prevent disease progression or even prevent disease onset entirely.